The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?Cannabinoid receptor type-1: breaking the dogmasRoles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseasesN-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients.Endocannabinoid signalling: has it got rhythm?Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.Key role of CRF in the skin stress response system.Skin phototype: a new perspective.Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitisTRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammationThe endocannabinoid system and cancer: therapeutic implication.CB(1) cannabinoid receptors and their associated proteins.Endocannabinoid signaling at the periphery: 50 years after THC.The itchy scalp--scratching for an explanation.Stress and skin leukocyte trafficking as a dual-stage processOn the role of skin in the regulation of local and systemic steroidogenic activities.Cannabinoid CB₂ receptors are involved in the regulation of fibrogenesis during skin wound repair in miceA novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ.Modulating the endocannabinoid system in human health and disease--successes and failuresCharacterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons.Mustard vesicants alter expression of the endocannabinoid system in mouse skin.Endogenous N-acyl taurines regulate skin wound healing.Epigenetic control of skin differentiation genes by phytocannabinoids.Brain region-specific changes in N-acylethanolamine contents with time of day."Sebocytes' makeup": novel mechanisms and concepts in the physiology of the human sebaceous glands.Safety assessment of diethanolamides as used in cosmetics.Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling.Harnessing neuroendocrine controls of keratin expression: a new therapeutic strategy for skin diseases?Safety Assessment of Ethanolamides as Used in Cosmetics.What is new in the pathophysiology of acne, an overview.Revisiting CB1 receptor as drug target in human melanoma.Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1) receptors: a keratinocyte-dependent effect.Dermatological aspects of synthetic cannabinoid addiction.Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor.Targeting Cutaneous Cannabinoid Signaling in Inflammation - A "High"-way to Heal?Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo.Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study.Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.
P2860
Q24633122-ECBC76F9-C1BE-4921-936D-6BE175E19811Q26745261-AC26E353-6AE6-46A9-B05B-92808DA8B206Q28079028-58868BBE-4B8B-49F5-8FD3-A3EFE742EE77Q33952688-CF4AD6DA-17A8-45CE-8A51-D46B497DCF4EQ34098217-6C455041-EC0B-49D7-B914-B0BC0ACE30FFQ34117612-4374672F-91E9-459B-B1F1-CA796D04545EQ34294075-C6D96E2D-ABD9-44AF-A4E3-932569670B5EQ34363640-D395C48B-F1A7-4BC8-948C-2A041E9B8D56Q34467780-88051BF6-7D07-4158-9B86-2A7E8939FFC5Q34488693-BD8D3117-6D44-4BD4-8CDA-8E9AF5F0B052Q34555762-3565FD9E-A56E-4808-B873-69F2B2CDF973Q35193299-896E3BD0-FD60-4C8D-8067-548812799A95Q35232109-66327330-B42B-4DA9-85E6-33AA514C893FQ35572176-5A698AE8-DECC-43AE-BFF1-9E14591F12A5Q35602011-01DF2ADC-3656-4156-9812-AA658DD9594BQ35661107-B8A0B817-1A9B-4516-9772-B3272E1181C1Q36244943-D46042B6-3450-408A-B9AD-EDDA223E950AQ36722133-814B1BAA-D17B-44CE-A1B7-C91A6FEF09CBQ36773315-D0F4376B-F210-4379-BFB4-790B92B0E508Q36933683-90965D13-A5EA-49AD-ACAA-E8FE4F8581A8Q36990269-9F0732A1-D65B-46CE-98C6-6007E1F0E7FBQ37099962-01467B4F-D575-4DA9-908B-72BF44EE6F92Q37142854-7DF3D8E0-837F-440A-AE37-3A5E176205E5Q37219086-D942AE32-0AEB-428F-AFEA-4EF3C377B92DQ37624013-BF5BC56D-9517-4C53-8857-DA2E267D7192Q37850705-AF8A630C-5DC6-4443-801F-02FBA94E2C5FQ38108596-35C12372-873A-45F6-8633-17E5E255FA57Q38185067-966F95F1-1E87-45DE-B1DF-700A9264A0CDQ38211479-9CAD818F-B25C-4580-B9A7-75EEC88F8831Q38557943-52C7A61C-CCA3-48C4-9891-AC4EF6AC1FE9Q38642921-14D68A30-7182-4C31-A20E-D7D8EC135905Q39374200-CC13B2BA-A782-47FA-9810-854CDA4F7C37Q39596907-4BC2A351-43F5-4DF4-998A-12870C1068E5Q39877690-6CA482C0-1445-4E08-B929-D7E071B12BCAQ42150825-1D657F45-B9A4-4EA4-9A07-65750F14ABDEQ42197634-462DDF4E-FEA1-4F35-85FB-2905BC3DE92CQ45288114-8D32F0C3-504D-4F5B-B5A2-4C8B38034FF2Q46425570-8B0D22DC-A7A4-44A8-ABC1-A4347AFE5A51Q47986677-FC6D21FD-CB6E-4E27-A143-2EE8A5524491Q48326461-0D7A5A3F-27B2-4783-90FF-57806DDE8946
P2860
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The endocannabinoid system of ...... and therapeutic opportunities.
@en
The endocannabinoid system of ...... and therapeutic opportunities.
@nl
type
label
The endocannabinoid system of ...... and therapeutic opportunities.
@en
The endocannabinoid system of ...... and therapeutic opportunities.
@nl
prefLabel
The endocannabinoid system of ...... and therapeutic opportunities.
@en
The endocannabinoid system of ...... and therapeutic opportunities.
@nl
P2860
P50
P1476
The endocannabinoid system of ...... and therapeutic opportunities.
@en
P2093
György Haskó
Tamás Bíró
P2860
P304
P356
10.1016/J.TIPS.2009.05.004
P577
2009-07-14T00:00:00Z